A synthetic dengue virus antigen elicits enhanced antibody titers when linked to, but not mixed with, Mycobacterium tuberculosis HSP70 domain II

Vaccine
Rajesh KolliS Swaminathan

Abstract

Domain II of Mycobacterium tuberculosis (Mtb) heat shock protein 70 (HSP70), spanning amino acid residues 161-370, was covalently linked to a recently described synthetic dengue virus antigen to study the influence of the former on the immunogenicity of the latter. Using an enzyme-linked immunosorbent assay, dengue antigen-specific antibody titers elicited by the fusion protein in Balb/c mice were an order of magnitude higher than those elicited by either the synthetic dengue antigen alone or a physical mixture of the dengue antigen plus Mtb HSP70 domain II protein. Our data demonstrate that (i) Mtb HSP70 domain II is capable of potentiating B-cell response and (ii) it should be covalently linked to the target antigen to do so.

References

Jan 2, 1992·Nature·M J Gething, J Sambrook
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·K LiberekM Zylicz
Jan 1, 1990·Medical Microbiology and Immunology·S H Kaufmann
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·K SuzueR A Young
Mar 15, 2002·The Lancet Infectious Diseases·María G Guzmán, Gustavo Kourí
Jun 29, 2002·BMJ : British Medical Journal·Robert V Gibbons, David W Vaughn
Oct 29, 2002·Lancet·Scott B Halstead, Jacqueline Deen
Apr 17, 2003·Developmental and Comparative Immunology·Jacques Robert
Jul 10, 2003·Current Opinion in Biotechnology·Tikki Pang
Aug 21, 2003·Lancet·A Graham Pockley
Sep 27, 2003·Methods : a Companion to Methods in Enzymology·Hanns Hauser, Si-Yi Chen
Dec 19, 2003·Protein Expression and Purification·Smita JaiswalSathyamangalam Swaminathan
Apr 2, 2004·The Journal of Clinical Investigation·Alan L Rothman
Apr 2, 2005·Protein Expression and Purification·Ravulapalli AnandaRaoNavin Khanna
Jan 24, 2006·Clinical and Vaccine Immunology : CVI·Ravulapalli AnandaraoNavin Khanna

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.